Innovative Targeting Solutions Inc.
309-4475 Wayburne Drive
About Innovative Targeting Solutions Inc.Innovative Targeting Solutions Inc. is a privately-held company that has developed a next generation protein engineering platform for the generation of fully human antibody and T-cell receptor based therapeutics using its proprietary HuTARG™ technology. The HuTARG™ technology is a fully mammalian technology that generates antibody diversity in vitro via RAG1/RAG2 mediated V(D)J
CSO: Paul S. Kang
Please click here for clinical trial information.
3 articles about Innovative Targeting Solutions Inc.
Innovative Targeting Solutions Inc., (ITS) the global leader in the discovery and optimization of antibodies, today announced a research collaboration with Sanofi.